Senti Biosciences (SNTI) Other financing activities (2021 - 2025)

Senti Biosciences' quarterly Other financing activities came in at $12000.0 in Q3 2025, down 97.75% quarter-over-quarter from $533000.0 in Q2 2025.

Senti Biosciences has reported Other financing activities for 3 years, with the latest figure at $12000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $12000.0; the trailing twelve-month figure through Dec 2025 stood at $2.5 million (up 978.17% YoY), and the FY2025 full-year result was $2.5 million, up 2369.0% from the prior year.
  • Other financing activities for Q3 2025 stood at $12000.0, down from $533000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.9 million in Q1 2025, with the low at $12000.0 in Q3 2025.
  • Average Other financing activities over 3 years is $609755.7, with a median of $523430.0 recorded in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Senti Biosciences Holdings 22.25 Mn 22.25 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 12,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 533,000.00
Jun 30, 2025 533,000.00
Mar 31, 2025 1.92 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 229,000.00
Dec 31, 2024 229,000.00
Dec 31, 2021 523,430.00
Dec 31, 2021 523,430.00
Sep 30, 2021 523,430.00
Sep 30, 2021 523,430.00
Jun 30, 2021 523,430.00
Jun 30, 2021 523,430.00